Mail-in Abortion Care During the Pandemic: A Reproductive Rights Victory
A federal court ruled on Monday, July 13, that the Food and Drug Administration (FDA) must suspend a rule requiring that patients seeking medication abortion—a combination of two drugs, mifepristone and misoprostol—must pick it up from their abortion care provider. Instead, in light of the COVID-19 pandemic, the drugs may now be mailed to patients. Read more …
